BRIEF published on 07/24/2026 at 07:05, 3 months 5 days ago BB Biotech AG annonce des résultats intermédiaires et ajuste sa politique de dividendes. Politique De Dividendes Portefeuille D'investissement BB Biotech Rapport Intérimaire Gain Net
BRIEF published on 07/24/2026 at 07:05, 3 months 5 days ago BB Biotech T2 2026 : Forte performance de l’actif net grâce à des investissements stratégiques Investissements Stratégiques Politique De Dividendes Diversification Du Portefeuille Activité De Fusions Et Acquisitions Performance En Biotechnologie
BRIEF published on 07/24/2026 at 07:05, 3 months 5 days ago BB Biotech Q2 2026: Robust NAV Performance Amid Strategic Investments Portfolio Diversification Dividend Policy Strategic Investments M&A Activity Biotechnology Performance
PRESS RELEASE published on 07/24/2026 at 07:00, 3 months 5 days ago EQS-Adhoc: BB Biotech AG publishes its interim report and revises its dividend policy BB Biotech AG publishes its interim report for the first half of 2026, reporting a net gain and revising its dividend policy. Details at www.bbbiotech.ch Financial Results Investment Company Dividend Policy BB Biotech AG Interim Report
PRESS RELEASE published on 07/24/2026 at 07:00, 3 months 5 days ago BB Biotech Q2 2026: Strong NAV outperformance driven by disciplined stock selection and portfolio positioning BB Biotech AG reports strong NAV outperformance in Q2 2026, driven by disciplined stock selection and portfolio positioning, new investments, and revised dividend policy Dividend Policy BB Biotech AG Stock Selection Q2 2026 NAV Outperformance
BRIEF published on 04/24/2026 at 07:05, 6 months 5 days ago BB Biotech AG Reports Q1 2026 Interim Results Drug Development Net Loss Investment Portfolio BB Biotech Q1 2026
BRIEF published on 04/24/2026 at 07:05, 6 months 5 days ago BB Biotech AG publie ses résultats intermédiaires du premier trimestre 2026 Perte Nette Portefeuille D'investissement Développement De Médicaments BB Biotech 1er Trimestre 2026
BRIEF published on 04/24/2026 at 07:05, 6 months 5 days ago BB Biotech Q1 2026 Achievements and Strategic Shifts Net Asset Value Portfolio Repositioning New Investments BB Biotech Performance Dividend Inclusion
BRIEF published on 04/24/2026 at 07:05, 6 months 5 days ago Réalisations et évolutions stratégiques de BB Biotech au premier trimestre 2026 Valeur Nette D'actif Nouveaux Investissements Performance De BB Biotech Repositionnement De Portefeuille Inclusion De Dividendes
PRESS RELEASE published on 04/24/2026 at 07:00, 6 months 5 days ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report for the first quarter of 2026, showing a net loss of CHF 21 mn compared to CHF 241 mn in the same period of 2025 Investment Company BB Biotech AG Interim Report Results Loss
Published on 10/29/2026 at 18:30, 2 hours 13 minutes ago Kidoz Inc. Appoints Derek Sentner as Chief Revenue Officer
Published on 10/29/2026 at 16:05, 4 hours 38 minutes ago SouthGobi Announces Date of Special Meeting of Shareholders and The Record Date
Published on 10/29/2026 at 13:31, 7 hours 12 minutes ago First Breach Advances Ammunition and Drone Manufacturing Expansion as U.S. Reshoring Accelerates
Published on 10/29/2026 at 13:00, 7 hours 43 minutes ago NuRAN Wireless Secures US$10 Million Non-Dilutive Facility and Confirms No ATM Sales at Current Market Levels
Published on 10/29/2026 at 13:00, 7 hours 43 minutes ago Core Silver Unveils Multiple New Broad Copper-Bearing VMS Intercepts at the Touleary Discovery Zone
Published on 10/29/2026 at 20:13, 29 minutes ago Interim individual financial statements of Sirma Group JSC for the period ending on September 30, 2026
Published on 10/29/2026 at 20:07, 36 minutes ago EQS-Adhoc: Instone Real Estate Group SE: Forecast lowered due to deterioration in the transaction environment
Published on 10/29/2026 at 19:25, 1 hour 17 minutes ago EQS-Adhoc: ProSiebenSat.1 Media SE expects a slight decline in organic revenues but reaffirms EBITDA growth outlook
Published on 10/29/2026 at 19:15, 1 hour 28 minutes ago TerraMaster invite les développeurs à co-développer l’écosystème TOS grâce à des récompenses pour la publication d’applications
Published on 10/29/2026 at 18:02, 2 hours 41 minutes ago TF1 9M 2026 results - Consolidated financial statements and appendix
Published on 10/29/2026 at 18:02, 2 hours 41 minutes ago Résultats TF1 9M 2026 - Comptes consolidés et annexes aux comptes
Published on 10/29/2026 at 18:00, 2 hours 43 minutes ago GUILLEMOT CORPORATION: THIRD-QUARTER 2026 TURNOVER / Successful new product launches and acceleration of international commercial partnerships
Published on 10/29/2026 at 18:00, 2 hours 43 minutes ago GUILLEMOT CORPORATION : CHIFFRE D’AFFAIRES TROISIEME TRIMESTRE 2026 / Succès des nouveaux lancements et accélération des partenariats commerciaux internationaux
